In ₹ Crore except Per Share Latest Annual	TECILCHEM FY26	BALAMINES FY26	ELLEN FY26	ALKYLAMINE FY26	Peer Average
Valuation — at last close
P/E	—	◆ 35.83×	42.44×	—	39.13×
P/B	—	◆ 3.03×	4.62×	—	3.82×
EV/EBITDA	◆ -75.02×	22.71×	39.02×	—	30.86× -343%
Market Cap	₹16.2 Cr	₹5,990 Cr	₹4,510 Cr	—	₹5,250 Cr -100%
Growth
Revenue CAGR 3Y	—	-15.42%	—	—	-15.42%
Revenue CAGR 5Y	0.00%	◆ 1.67%	—	—	1.67% -100%
Net Income CAGR 3Y	—	-25.29%	—	—	-25.29%
Revenue YoY (latest Q)	—	◆ 27.23%	18.04%	—	22.63%
Net Income YoY (latest Q)	-171.61%	◆ 113.86%	86.84%	—	100.35% -271%
Profitability
EBITDA Margin	—	18.63%	◆ 34.02%	—	26.33%
Net Income Margin	-424700.00%	11.87%	◆ 30.56%	—	21.21% -2001985%
Return on Common Equity	2.30%	8.85%	◆ 10.68%	—	9.77% -76%
Return on Capital Employed	7.44%	◆ 9.37%	8.52%	—	8.95% -17%
Return on Assets	-9.76%	6.77%	◆ 8.04%	—	7.40% -232%
Credit & Quality
Total Debt/Equity	◆ -0.69×	0.06×	0.18×	—	0.12× -675%
Interest Coverage	—	◆ 38.93×	9.98×	—	24.45×
Scale — latest FY
Revenue / Total Income	₹0 Cr	₹1,425 Cr	₹342 Cr	—	₹883 Cr -100%
Net Income	−₹0.4 Cr	₹169 Cr	₹104 Cr	—	₹137 Cr -100%
Total Assets	₹4.3 Cr	₹2,743 Cr	₹1,299 Cr	₹1,895 Cr	₹1,979 Cr -100%
EPS	₹-0.22	₹51.6	₹7.54	—	₹29.57 -101%
Book Value per Share	₹-9.85	₹610	₹69.33	—	₹339.67 -103%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.